Kinin B1 Receptors Contributes to Acute Pain Following Minor Surgery in Humans

Overview

Journal Mol Pain

Date 2010 Feb 16

PMID 20152050

Citations 14

Authors

May Hamza

Xiao-Min Wang

Albert Adam

Jaime S Brahim

Janet S Rowan

Gilberto N Carmona

Raymond A Dionne

Affiliations

Soon will be listed here.

Abstract

Background: Kinins play an important role in regulation of pain and hyperalgesia after tissue injury and inflammation by activating two types of G-protein-coupled receptors, the kinin B1 and B2 receptors. It is generally accepted that the B2 receptor is constitutively expressed, whereas the B1 receptor is induced in response to inflammation. However, little is known about the regulatory effects of kinin receptors on the onset of acute inflammation and inflammatory pain in humans. The present study investigated the changes in gene expression of kinin receptors and the levels of their endogenous ligands at an early time point following tissue injury and their relation to clinical pain, as well as the effect of COX-inhibition on their expression levels.

Results: Tissue injury resulted in a significant up-regulation in the gene expression of B1 and B2 receptors at 3 hours post-surgery, the onset of acute inflammatory pain. Interestingly, the up-regulation in the gene expression of B1 and B2 receptors was positively correlated to pain intensity only after ketorolac treatment, signifying an interaction between prostaglandins and kinins in the inflammatory pain process. Further, the gene expression of both B1 and B2 receptors were correlated. Following tissue injury, B1 ligands des-Arg9-BK and des-Arg10-KD were significantly lower at the third hour compared to the first 2 hours in both the placebo and the ketorolac treatment groups but did not differ significantly between groups. Tissue injury also resulted in the down-regulation of TRPV1 gene expression at 3 hours post-surgery with no significant effect by ketorolac treatment. Interestingly, the change in gene expression of TRPV1 was correlated to the change in gene expression of B1 receptor but not B2 receptor.

Conclusions: These results provide evidence at the transcriptional level in a clinical model of tissue injury that up-regulation of kinin receptors are involved in the development of the early phase of inflammation and inflammatory pain. The up-regulation of B1 receptors may contribute to acute inflammatory pain through TRPV1 activation.

Citing Articles

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons.

Yi J, Bertels Z, Del Rosario J, Widman A, Slivicki R, Payne M Pain. 2023; 165(1):202-215.

PMID: 37703419 PMC: 10723647. DOI: 10.1097/j.pain.0000000000003013.

Kinins' Contribution to Postoperative Pain in an Experimental Animal Model and Its Implications.

Brusco I, Silva C, Ferreira J, Oliveira S Brain Sci. 2023; 13(6).

PMID: 37371419 PMC: 10296021. DOI: 10.3390/brainsci13060941.

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons.

Yi J, Bertels Z, Del Rosario J, Widman A, Slivicki R, Payne M bioRxiv. 2023; .

PMID: 37034782 PMC: 10081334. DOI: 10.1101/2023.03.31.534820.

Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression.

Arnhold J Int J Mol Sci. 2023; 24(3).

PMID: 36769331 PMC: 9918110. DOI: 10.3390/ijms24033016.

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis.

Meng X, Li Y, Li Q, Yang J, An M, Fu X Exp Ther Med. 2021; 22(5):1240.

PMID: 34539836 PMC: 8438668. DOI: 10.3892/etm.2021.10675.

References

Levy D, Zochodne D . Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain. 2000; 86(3):265-271. DOI: 10.1016/S0304-3959(00)00256-6. View

Passos G, Fernandes E, Campos M, Araujo J, Pesquero J, Souza G . Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J Immunol. 2004; 172(3):1839-47. DOI: 10.4049/jimmunol.172.3.1839. View

Bastian S, Loillier B, Paquet J, Pruneau D . Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization. Br J Pharmacol. 1997; 122(2):393-9. PMC: 1564937. DOI: 10.1038/sj.bjp.0701380. View

Moreau M, Garbacki N, Molinaro G, Brown N, Marceau F, Adam A . The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005; 99(1):6-38. DOI: 10.1254/jphs.srj05001x. View

Wang X, Hamza M, Wu T, Dionne R . Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain. 2009; 142(3):275-283. PMC: 3513699. DOI: 10.1016/j.pain.2009.02.001. View

DomBourian M, Turner N, Gerovac T, Vemuganti R, Miranpuri G, Tureyen K . B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine (Phila Pa 1976). 2006; 31(24):2778-82. DOI: 10.1097/01.brs.0000245865.97424.b4. View

Kanai Y, Nakazato E, Fujiuchi A, Hara T, Imai A . Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology. 2005; 49(7):977-84. DOI: 10.1016/j.neuropharm.2005.05.003. View

Brechter A, Persson E, Lundgren I, Lerner U . Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases. Bone. 2008; 43(1):72-83. DOI: 10.1016/j.bone.2008.02.003. View

Pan Z, Zuraw B, Lung C, Prossnitz E, Browning D, Ye R . Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts. J Clin Invest. 1996; 98(9):2042-9. PMC: 507648. DOI: 10.1172/JCI119009. View

10.

Reilly C, Taylor J, Lanza D, Carr B, Crouch D, Yost G . Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. Toxicol Sci. 2003; 73(1):170-81. PMC: 2423488. DOI: 10.1093/toxsci/kfg044. View

11.

Couture R, Harrisson M, Vianna R, Cloutier F . Kinin receptors in pain and inflammation. Eur J Pharmacol. 2001; 429(1-3):161-76. DOI: 10.1016/s0014-2999(01)01318-8. View

12.

Marney A, Ma J, Luther J, Ikizler T, Brown N . Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol. 2009; 20(10):2246-52. PMC: 2754101. DOI: 10.1681/ASN.2009050505. View

13.

Shin J, Cho H, Hwang S, Jung J, Shin C, Lee S . Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci U S A. 2002; 99(15):10150-5. PMC: 126639. DOI: 10.1073/pnas.152002699. View

14.

Sufka K, Roach T . Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats. Pain. 1996; 66(1):99-103. DOI: 10.1016/0304-3959(96)02990-9. View

15.

Miyamoto R, Tokuda M, Sakuta T, Nagaoka S, Torii M . Expression and characterization of vanilloid receptor subtype 1 in human dental pulp cell cultures. J Endod. 2005; 31(9):652-8. DOI: 10.1097/01.don.0000155259.22746.ae. View

16.

Szallasi A, Cortright D, Blum C, Eid S . The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007; 6(5):357-72. DOI: 10.1038/nrd2280. View

17.

Phagoo S, Yaqoob M, McIntyre P, Jones C, Burgess G . Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol. 2000; 397(2-3):237-46. DOI: 10.1016/s0014-2999(00)00323-x. View

18.

Shirasaki H, Kanaizumi E, Himi T . Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm. 2009; 2009:102406. PMC: 2673475. DOI: 10.1155/2009/102406. View

19.

Mayer S, Izydorczyk I, Reeh P, Grubb B . Bradykinin-induced nociceptor sensitisation to heat depends on cox-1 and cox-2 in isolated rat skin. Pain. 2007; 130(1-2):14-24. DOI: 10.1016/j.pain.2006.10.027. View

20.

Phagoo S, Poole S . Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol. 1999; 56(2):325-33. DOI: 10.1124/mol.56.2.325. View